Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis. [PDF]
Minbaeva S, Tyring SK.
europepmc +1 more source
Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation. [PDF]
Valent P +15 more
europepmc +1 more source
ISM-1 expression in cutaneous mastocytosis: Diagnostic potential and comparison with CD117. [PDF]
Kaya Ş +5 more
europepmc +1 more source
Eosinophilic and mastocytic gastrointestinal diseases: current knowledge and controversy in histopathologic diagnosis. [PDF]
Yu W, Wang HL.
europepmc +1 more source
Near-Fatal Mastocytosis Mimicking as Malignant Vasovagal Syncope. [PDF]
Estublier B +7 more
europepmc +1 more source
Diffuse red-brown papules in a toddler. [PDF]
Phong CH, Kasheri E, Lee BA, Smith J.
europepmc +1 more source
Multiphasic anaphylaxis in the emergency and intensive care setting. [PDF]
Schneider MA, de Groot H, Geerts JW.
europepmc +1 more source
Diagnostic Challenges in a Young Man with a Suspected Mast Cell Disorder, Dysplastic Bone Marrow Morphology, and a <i>ZRSR2</i> Mutation. [PDF]
Dondolin R +7 more
europepmc +1 more source
Relapse of Acute Myeloid Leukemia With Concomitant Systemic Mastocytosis Five Years Post Allogenic Hematopoietic Stem Cell Transplantation. [PDF]
Vardanyan S +5 more
europepmc +1 more source
Avapritinib and corticosteroids in advanced systemic mastocytosis with tumoral CMML and associated thrombocytopenia. [PDF]
Abakarim O +7 more
europepmc +1 more source

